Published in N Engl J Med on June 02, 2005
Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis (2008) 4.46
Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis (2009) 2.74
Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc (2009) 2.35
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med (2010) 2.01
Update on herpes zoster vaccination: a family practitioner's guide. Can Fam Physician (2011) 1.74
Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells. Blood (2009) 1.62
The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health (2005) 1.57
Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection (2011) 1.52
Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc (2009) 1.42
Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials. J Acquir Immune Defic Syndr (2010) 1.24
Signaling pathways in aged T cells - a reflection of T cell differentiation, cell senescence and host environment. Semin Immunol (2012) 1.18
Administration of Vitamin C in a Patient with Herpes Zoster - A case report -. Korean J Pain (2011) 1.13
Impact of herpes zoster and post-herpetic neuralgia on patients' quality of life: a patient-reported outcomes survey. Z Gesundh Wiss (2010) 1.08
Immune aging and rheumatoid arthritis. Rheum Dis Clin North Am (2010) 1.05
The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study. Br J Cancer (2013) 1.02
The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. Z Gesundh Wiss (2011) 0.98
Immunosupportive therapies in aging. Clin Interv Aging (2007) 0.97
Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment. Korean J Pain (2015) 0.96
Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci (2012) 0.93
Herpes zoster and exposure to the varicella zoster virus in an era of varicella vaccination. Am J Public Health (2010) 0.92
Management and prevention of herpes zoster: A Canadian perspective. Can J Infect Dis Med Microbiol (2010) 0.92
Disseminated herpes zoster in an immunocompetent elderly patient. Korean J Pain (2013) 0.92
Postherpetic neuralgia in the elderly. Int J Clin Pract (2009) 0.90
Herpes zoster vaccine in Korea. Clin Exp Vaccine Res (2013) 0.88
Implication of human herpesviruses in oncogenesis through immune evasion and supression. Infect Agent Cancer (2014) 0.87
Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications. Clin Infect Dis (2013) 0.87
Herpes zoster and subsequent risk of cancer: a population-based study. J Epidemiol (2013) 0.86
Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections. Eur J Clin Microbiol Infect Dis (2016) 0.84
Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan. PLoS One (2015) 0.82
Asthma as a risk factor for zoster in adults: A population-based case-control study. J Allergy Clin Immunol (2015) 0.81
Reducing the burden of Herpes Zoster in Italy. Hum Vaccin Immunother (2014) 0.79
Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis. Clinics (Sao Paulo) (2013) 0.77
ARIZONA study: is the risk of post-herpetic neuralgia and its burden increased in the most elderly patients? BMC Infect Dis (2014) 0.77
Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years. Hum Vaccin (2011) 0.77
T cell senescence and cardiovascular diseases. Clin Exp Med (2015) 0.76
Herpes zoster as a risk factor for osteoporosis: A 15-year nationwide population-based study. Medicine (Baltimore) (2016) 0.76
Diffusion tensor magnetic resonance imaging of trigeminal nerves in relapsing herpetic keratouveitis. PLoS One (2015) 0.76
Herpes zoster as a sign of AIDS and nonadherence to antiretroviral therapy: a case report. Clinics (Sao Paulo) (2011) 0.76
Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study. BMC Infect Dis (2014) 0.76
The societal impact of herpes zoster and postherpetic neuralgia on patients, life partners, and children of patients in Germany. ScientificWorldJournal (2014) 0.76
Disseminated cutaneous herpes zoster in an immunocompetent elderly patient. Infect Dis Rep (2014) 0.75
Corneal Reinnervation and Sensation Recovery in Patients With Herpes Zoster Ophthalmicus: An In Vivo and Ex Vivo Study of Corneal Nerves. Cornea (2016) 0.75
Herpes Zoster and Risk of Cancer in the Elderly U.S. Population. Cancer Epidemiol Biomarkers Prev (2015) 0.75
Fulminant varicella zoster infection with multiorgan involvement: a case report. Sultan Qaboos Univ Med J (2008) 0.75
Initial Presentation Sites as Predictors of Herpes Zoster Complications: A Nationwide Cohort Study. PLoS One (2016) 0.75
Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis. BMC Infect Dis (2015) 0.75
Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean J Pain (2016) 0.75
Varicella-zoster virus associated encephalitis in a patient undergoing haemodialysis. Qatar Med J (2016) 0.75
Enhanced Viral Replication by Cellular Replicative Senescence. Immune Netw (2016) 0.75
Herpes zoster and postherpetic neuralgia in Catalonia (Spain). Hum Vaccin Immunother (2014) 0.75
Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. BMJ Open (2017) 0.75
Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea. Hum Vaccin Immunother (2015) 0.75
Microbiology laboratory and the management of mother-child varicella-zoster virus infection. World J Virol (2016) 0.75
Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest (2017) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06